{
    "nctId": "NCT02430103",
    "briefTitle": "Study of Preservation of Ovarian Reserve During Chemotherapy for Young Breast Cancer Patients",
    "officialTitle": "Effect of Goserelin on the Protection of Ovarian Reserve During (Neo)Adjuvant Chemotherapy for Young Breast Cancer Patients: A Prospective Cohort Trial",
    "overallStatus": "RECRUITING",
    "conditions": "Breast Cancer",
    "studyType": "OBSERVATIONAL",
    "phase": "N/A",
    "allocation": "N/A",
    "primaryPurpose": "N/A",
    "enrollmentCount": 240,
    "primaryOutcomeMeasure": "Recovery of serum AMH value(\u22650.5ng/ml) in 2 years of post-chemotherapy",
    "eligibilityCriteria": "Inclusion Criteria:\n\nFor inclusion in the study patients must fulfil all of the following criteria:\n\n1. Aged 45 years or younger\n2. Have regular menstrual cycle\n3. Newly diagnosed early-stage breast cancer (stages I to III)\n4. Planned (neo)adjuvant chemotherapy\n5. Signed informed consent document on file\n\nExclusion Criteria:\n\nAny of the following is regarded as a criterion for exclusion from the study:\n\n1. Pregnancy or lactation\n2. Oral contraceptives before enrollment\n3. Prior chemotherapy\n4. Bilateral oophorectomy or ovarian irradiation before enrollment\n5. History of other cancers\n6. GnRHa -containing adjuvant endocrine therapy",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT"
}